SOSV on X

SOSV is a United States specialist venture firm and accelerator operator focused on deep tech for human and planetary health. On sosv.com the mission is to fund deep-tech founders at inception—often their first cheque—with general partners working beside them. The firm emphasises resourced labs, offices, and event space as part of that support. Programmes named on the official pages include HAX and IndieBio, with 2026 language about SOSV SF and SOSV NY. Investing starts at pre-seed when companies join programmes and can continue after, the firm says, into seed, Series A, and beyond. SOSV prints an assets-under-management figure of one and a half billion dollars, names a core fund SOSV V, and describes a Genesis Consortium that can provide an additional two hundred fifty thousand dollars to qualifying startups. Limited-partner examples the site lists include Credit Suisse, the Irish Strategic Investment Fund, Pfizer Ventures, and Honda. Founder demographics the firm reports include eighty-two nationalities across fifty-eight countries, forty-four percent with doctorates, and thirty-two percent of companies with at least one female founder. Offices listed include San Francisco, New York, Newark, Cork, Pune, Shenzhen, and Tokyo. Founding credit goes to Sean O’Sullivan in 1995. Cite every figure as SOSV’s own snapshot. Rank 49 SOSV LLC is the same house and is not imported twice. Official X is SOSV. Official LinkedIn is sosv. Official YouTube is channel UCr3_edKFdOwK6I5L081Zy5Q. Those channels carry lab films and programme notes. They are not a fundraising desk and not a place to share OTP, wire details, or unpublished science. None of this is investment advice or a solicitation to invest. Follow official SOSV pages, then verify every lab, fund, and office line on sosv.com. SOSV also notes HAX Plasma Forge work with public partners, IndieBio’s 2015 San Francisco opening and 2020 New York opening, a 2026 renaming of IndieBio language to SOSV NY and SOSV SF, and a Deep Tech 100 list it publishes. It says it contributes ten percent of firm profits to charity and that some consortium names such as dlab and Orbit Startups became independent in 2023. Early-2026 portfolio colour on the site includes eight hundred active companies that had raised seven point three billion dollars. Cite those lines as SOSV’s own. They are not a live Bloomberg page. Keep lab access codes off YouTube comments.